Evaluating Cordyceps militaris capsules on post-bronchodilator FEV1 decline in patients with COPD: a study protocol for double-blind, randomized, placebo-controlled trial.
Saved in:
| Title: | Evaluating Cordyceps militaris capsules on post-bronchodilator FEV |
|---|---|
| Authors: | Lin S; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China., Liao T; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China., Fan F; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangdong Provincial Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou, China., Chen Y; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangdong Provincial Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou, China., Yan Y; China-Japan Friendship Hospital, Beijing, China., Dong H; Nanfang Hospital Southern Medical University, Guangzhou, China., Zhan S; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China., Zhang Y; Jiangxi Provincial Hospital of Chinese Medicine, Nanchang, China., Xiao K; The Second People's Hospital of Baiyun and Guangzhou, Guangzhou, China., Lin L; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangdong Provincial Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou, China., Wu L; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangdong Provincial Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 May 25; Vol. 17, pp. 1775068. Date of Electronic Publication: 2026 May 25 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42266370 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Evaluating Cordyceps militaris capsules on post-bronchodilator FEV<subscript>1</subscript> decline in patients with COPD: a study protocol for double-blind, randomized, placebo-controlled trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lin+S%22">Lin S</searchLink>; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Liao+T%22">Liao T</searchLink>; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Fan+F%22">Fan F</searchLink>; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangdong Provincial Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangdong Provincial Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Yan+Y%22">Yan Y</searchLink>; China-Japan Friendship Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Dong+H%22">Dong H</searchLink>; Nanfang Hospital Southern Medical University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhan+S%22">Zhan S</searchLink>; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Jiangxi Provincial Hospital of Chinese Medicine, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Xiao+K%22">Xiao K</searchLink>; The Second People's Hospital of Baiyun and Guangzhou, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Lin+L%22">Lin L</searchLink>; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangdong Provincial Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Wu+L%22">Wu L</searchLink>; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangdong Provincial Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2026 May 25; Vol. 17, pp. 1775068. <i>Date of Electronic Publication: </i>2026 May 25 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42266370 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2026.1775068 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1775068 Titles: – TitleFull: Evaluating Cordyceps militaris capsules on post-bronchodilator FEV1 decline in patients with COPD: a study protocol for double-blind, randomized, placebo-controlled trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lin S – PersonEntity: Name: NameFull: Liao T – PersonEntity: Name: NameFull: Fan F – PersonEntity: Name: NameFull: Chen Y – PersonEntity: Name: NameFull: Yan Y – PersonEntity: Name: NameFull: Dong H – PersonEntity: Name: NameFull: Zhan S – PersonEntity: Name: NameFull: Zhang Y – PersonEntity: Name: NameFull: Xiao K – PersonEntity: Name: NameFull: Lin L – PersonEntity: Name: NameFull: Wu L IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 05 Text: 2026 May 25 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 17 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |